Professional Documents
Culture Documents
Immature/Acute Immature/Acute
Myeloid Lymphoid
Acute Myelogenous Acute Lymphocytic
Leukemias Leukemias
Myelodysplastic
Syndromes
Mature/Chronic Lymphoid
WBC 4,000/ul
Hgb 7.5 gm/dL Hct 22% RBC 2.4 x 106/ul MCV 91 fl Pancytopenia
Platelets 120,000/ul
Reticulocyte count 1%
Absolute Retics 22,000/ul Reticulocytopenia
Other labs
Normal B12, folate, homocysteine
Total protein 10 gm/dL (elevated) Albumin 3 gm/dL (decreased)
Creatinine 2.3 mg/dL Calcium normal
Normal SPEP
Case # 1
Plasma Cells
Tho MM patients have elevated monoclonal Ig, it does not provide immunity against a diverse range of pathogens; loss of polyclonal
immunoglobulins (hypogammaglobulinemia) results in risk of infection
Case # 1.5
A 65 year old man presents with a 6 month history of increasing
fatigue and dyspnea on exertion.
WBC 4,000/ul
Hgb 7.5 gm/dL Hct 22% RBC 2.4 x 106/ul Pancytopenia
Platelets 120,000/ul Reticulocytopenia
Retic count 1%
Absolute Retics 22,000/ul
WBC 20,000/ul
Leukocytosis
Hgb 11gm/dL Hct 33% RBC 3 x 106/ul
Anemia
Platelets 150,000/ul
Case # 2
A 23 year old man presents with cervical adenopathy.
WBC 20,000/ul
Leukocytosis
Hgb 11 gm/dL Hct 33% RBC 3 x 106/ul
Anemia
Platelets 150,000/ul
Reticulocyte count: 5%
Absolute reticulocytes: 150,000/ul
Blood Smear
Mature
lymphocytes What next?
Case # 2
Why is he anemic?
Why does he have splenomegaly?
Case # 3
A 40 year old woman presents with right calf pain and
swelling and is found to have a deep vein thrombosis. She has a 6
month history of fatigue, headaches and menometrorrhagia.
Normal LFTs
Normal
Chemistries
Case #5
Case # 6
An asymptomatic
70 year old woman with small,
non-tender nodes in neck, axilla,
groin
Lymphomas
History: Diagnosis
Age
Onset/duration of symptoms
Fevers, night sweats, weight loss
HIV? Pathology
Immunophenotype
Exam Genotype
Adenopathy
Splenomegaly Hodgkin
Non-Hodgkin
Histologic subtype Staging determines
Staging determines treatment treatment and prognosis
and prognosis
Treatment
?Curable
?Risk vs benefit
LN biopsy:
Staging:
PET: mediastinal and retroperitoneal adenopathy; normal liver,
spleen, GI tract
BM biopsy: negative for lymphoma
Staging:
PET: bilateral cervical, axillary, paraaortic, bulky mesenteric
adenopathy; hepatosplenomegaly; +bone lesions
BM biopsy: positive for lymphoma
LN biopsy: Follicular
lymphoma
CD20+
t(14;18)+
BCL-2+
Staging:
PET: small bilateral cervical, axillary and inguinal adenopathy
BM biopsy: positive for lymphoma
Reticulocyte count 1%
Absolute reticulocyte count 30,000/ul Blood Smear
Other labs:
EBV PCR positive
Potassium 5.8 mg/dL Uric acid 11 mg/dL Phosphorous 6 mg/dL Calcium 7 mg/dL
Peripheral Blood Smear
Immunohistochemistry:
CD20+, CD10+, kappa-light chain restricted,
Proliferation index: 100% (Ki-67)
Viruses and Cancer
Virus* Cancer*
EBV Endemic Burkitt’s (some sporadic)
Hodgkin lymphoma
Post transplant lymphoma (PTLD)
Nasopharyngeal Ca
Mononucleosis
HIV Kaposi’s sarcoma
(increased incidence) Anal cancer
Cervical Cancer
Non-Hodgkin lymphoma
Hodgkin Lymphoma
HTLV1 Adult T cell Leukemia Lymphoma
Primary Effusion Lymphoma
HHV8
Kaposi’s sarcoma
H. Pylori MALT lymphoma (marginal zone)
Marginal Zone lymphoma
Hepatitis C
Hepatocellular carcinoma (also Hep B)
Cervical Cancer
HPV
Oropharyngeal (pharynx, tonsil, tongue)
Disease Cytogenetics* Genes* Protein*
Acute Promyelocytic Leukemia t(15;17) pml-rar transcription factor
t(9;22) bcr-abl tyrosine kinase
Acute lymphoblastic leukemia
11q23 MLL
Myelodysplastic syndromes mono/del 5, 7
Myeloproliferative Neoplasms
JAK2V617F tyrosine kinase
(P. Vera, ET, Primary Myelofibrosis)
del 13q
Chronic lymphocytic leukemia
del 17p p53 tumor suppressor
del 13q
Multiple myeloma p53 tumor suppressor
del 17p
c-myc (8) transcription factor
Burkitt’s lymphoma t(8;14)
IgH gene
bcl-2 (18) bcl-2
Follicular lymphoma t(14;18) (anti-apoptosis)
IgH gene
IV Gamma Globulin Macrophage Fc Receptor Blockade Infusion Reactions AIHA, ITP, Hypo
PD-1, PDL-1 Inhibitors Activation of T cells against tumor Activation of T cells Being tried in all
(“itis” all organs)
Chemotherapy
Methotrexate Anti-metabolite (anti-folate) Renal, hepatic Leukemia, lymphoma
Which of the following most likely explains the patient’s bone changes?
A bcl2 overexpression
B bcr abl hybrid formation
C c-myc overexpression
D erb-B2 overexpression
E p53 inactivation
A 45 year old man presents with purulent nasal discharge, headache, sore throat and
cough. His PMH is only significant for mononucleosis at age 22. He smokes 1 pack of
cigarettes/day for the past 20 years.
Exam: Febrile; Maxillary tenderness; red throat; small, tender cervical adenopathy,
CBC: WBC 58,000/ul
WBC Differential: PMN 42%, Bands 1%, Metamyelocytes 8%, Myelocytes
30%, Blasts 1%, Eosinophils 6%, Basophils 4%
Leukocyte alkaline phosphatase (LAP) score is low
A biopsy of one of the bone lesions is most likely to show which of the following?
The genes translocated in these lymphoid cells produces a protein that is most
directly responsible for which of the following functions?
A Apoptosis inhibition
B DNA repair
C Regulation of G1 to S-phase transition
D Transcription activation
E Tyrosine kinase upregulation
A healthy 16 year old boy is seen with fever, malaise, sore throat and fatigue.
Exam: petechiae on palate and lower legs; bilateral cervical adenopathy; splenomegaly.
Blood smear: shown
Horse erythrocytes agglutinate when exposed to patient’s serum.
The agent causing this patient’s disease is most strongly associated with which of the following
malignancies?
A AML
B Cx carcinoma
C Hepatocellular carcinoma
D Kaposi’s
E MALT lymphoma
F Multiple Myeloma
G Nasopharyngeal
A 24 year old man comes to the oncology clinic for a follow up visit. He was
diagnosed with Hodgkin Lymphoma 4 months ago and received combination
chemotherapy. He has a non-productive cough, and dyspnea with exertion for the
past two weeks.
Exam: there is no jugular venous distension or pedal edema. Heart sounds are normal
with no murmur. Lung exam: bilateral fine inspiratory crackles.
CXR: bilateral reticular interstitial opacities.
PFTs: restrictive pattern with decreased diffusion capacity for carbon monoxide.
CXR and PFTs were normal prior to the start of chemo.
Which of the following is the most likely mechanism of action of medication causing
patient’s current symptoms?
Which of the following biologic agents can be added to the chemotherapy regimen
to improve response?
A Infliximab
B Rituximab
C IL-2
D Imatinib
E Abciximab
A 54 year old woman presents with 2 months of weakness, fatigue, abdominal pain
and early satiety. She has no significant past medical history and denies recent foreign
travel.
Exam: normal vital signs; massive splenomegaly; no adenopathy
CBC: pancytopenia
Bone marrow: Inaspirable
A Iron deficiency
B Cobalamin deficiency
C Chronic lymphocytic leukemia
D Aplastic anemia
E Plasma cell neoplasm
F Hodgkin lymphoma
G Hypothyroidism
A 68 year old man presents to his doctor’s office with persistent back pain for several months. He
is a retired veteran and has not seen his PCP for many years. He has smoked a pack of
cigarettes/day for 36 years.
Exam: B/P 145/85 Pulse 88/min Cardiopulmonary exam is normal
Abdomen is soft and non tender; There is focal tenderness over 10th rib and L1-L2 vertebral
region. Neurologic exam normal
A bone scan (radionuclide imaging) shows increased activity in multiple vertebrae and ribs,
corresponding to patient’s painful areas
Plain x-ray shows sclerotic lesions matching bone scan areas of increased uptake, which are highly
suspicious for metastatic cancer.
Which of the following additional findings is most likely to be seen in this patient?
Which of the following lab techniques would be most useful for identifying patients
with this genetic abnormality?
A Allopurinol
B Amifostine
C Dexrazoxane
D Filgrastim
E Folinic acid
F Mesna
G Ondansetron
A 65 year old patient presents with 4 months of worsening fatigue. He feels tired with
simple household chores. He has a 15 pack-year smoking history and drinks 2-3
beers/day.
Exam: afebrile; B/P 134/86 Pulse 76/min; late systolic ejection murmur with soft
S2; clear lungs; soft non tender abdomen; no hepatosplenomegaly
Normal neuro exam
CBC Hgb 9 g/dL MCV 93
Blood smear: shown
Which of the following best explains the observed erythrocyte findings in this
patient?
This medication helps protect normal organs by which of the following mechanisms?
Which of the following is most strongly correlated with this patient’s condition?
Which of the following is the most likely effect of this therapy on abnormal cells?
The drug responsible for this patient’s neurologic symptoms causes cell cycle arrest
during which of the following stages?
A GO
B M
C G1
D S
E G2
A 56 year old with man with non-Hodgkin’s lymphoma has received an overdose of
vincristine.
A BCL-2
B Calcineurin
C E-cadherin
D Neurofibromin
E p53
A 56 year old woman is seen in ED for evaluation of 3 days of frequent urination,
suprapubic pain, dysuria and progressive hematuria. She has no fever or chills. The
patient has a history of node-positive breast cancer diagnosed following a routine
mammogram. She started systemic chemotherapy one month ago.
Exam: afebrile; suprapubic tenderness on abdominal examination
Labs: Hgb 9.8 g/dL
U/A: numerous RBCs, but no leukocyte esterase or bacteria
Which of the following could have prevented this patient’s current condition?
A Dexrazoxane
B Filgrastim
C Folinic acid
D Mesna
E Ondansetron
A 62 year old woman is seen for progressive chest and back pain She noticed a right
breast lump several months ago, which enlarged. She has no significant past medical
history and has not seen a physician for many years. She has not had any cancer
screenings.
Exam: 5 cm hard mass in right breast; enlarged axillary adenopathy; point tenderness
along right sided ribs and 10th thoracic vertebra
Biopsy of breast mass: ER positive, PR positive, HER2-negative invasive ductal
carcinoma
Skeletal survey: lytic lesions of ribs and thoracic vertebrae
As part of the treatment regimen, the patient receives a medication that is a potent
inhibitor of cyclin-dependent kinase.
Which of the following is the most likely dose-limiting toxicity of this medication?
Which of the following cell surface receptors is most likely blocked by this
treatment?
A CCR5
B CD4
C CD19
D CD28
E PD-1
A 47 year old woman gravida 2 para 2 is seen after finding a pea-sized lump in her
right breast while showering. She has a 3 pack year smoking history, but stopped 20
years ago. She underwent infertility treatment and in vitro fertilization for both of her
pregnancies. There is no family history of breast or ovarian cancer.
Exam: a firm, fixed nodule is palpated in the right breast with a small patch of
overlying puckered skin
Mammogram: highly suspicious for malignancy
Needle biopsy of nodule: infiltrating ductal carcinoma
The patient is scheduled for a right mastectomy and axillary lymph node dissection.
A BCL-2
B Estrogen receptor
C Human epidermal growth factor receptor 2
D Mutated p53
E Progesterone receptor
The cells identified by the special immunohistochemical IHC stain on the breast nodule
biopsy in the patient described above is shown to overexpress 185 kD glycoprotein
that spans the cell membrane and has tyrosine kinase activity in the intracellular
domain.
A Estrogen receptor
B Peripheral aromatase enzyme
C Receptor activator of nuclear factor kappa-B ligand
D Tyrosine kinase receptor
E Vascular endothelial growth factor
Two antineoplastic drugs are shown to inhibit intracellular thymidylate formation. The
chemotherapeutic effect of drug X can be overcome by N5 formyl-tetrahydrofolate
supplementation, but that of drug Y is not affected.
The drugs described in this scenario are most likely which of the following?
X Y
A Cytarabine Gemcitabine
B Fluorouracil Leucovorin
C Fludarabine Methotrexate
D Methotrexate Fluorouracil
E Gemcitabine Fludarabine
In vivo studies demonstrate that tumor cell lines can become resistant after exposure
to various anticancer agents.
These cells express a specific cell surface glycoprotein that has which of the
following functions?
Which of following substances will most likely accumulate in the embroyonic tissues
as a result?
A Dihydrofolate polyglutamate
B Folinic acid
C Para-aminobnezoic acid
D Tetrahydrofolate
E Thymidylic acid
A 34 year old man with an unremarkable past medical history is being evaluated
for an enlarged lymph node in the anterior cervical chain that measures 4 cm in
diameter. He first felt the lymph node several weeks ago and says it has been
steadily increasing in size. He is concerned about whether or not he has cancer
and is referred to a specialist for surgical removal of the enlarged lymph node.
Biopsy reveals abnormal lymph node architecture and numerous lymphocytes.
A Lymphocyte pleomorphism
B Abundant mitotic figures within the lymph node
C Nuclear changes in lymphocytes
D Monoclonal T cell receptor gene rearrangements
E Admixture of several lymphoid cell types within the lymph node
A 34 year old woman comes to office after her sister was diagnosed with breast
cancer. She has no nipple discharge, breast lumps or discomfort. Breast exam is
normal. Her sister was found to have a multiple base pair insertion affecting exon
11 of the BRCA1 gene that leads to a frameshift mutation. A screening test to
evaluate for a similar insertion mutation in the patient’s BRCA1 gene is
performed. The test uses polymerase chain reaction (PCR) to amplify the target
exon and gel electrophoresis to assess the size of the exon compared to the wild-
tyle allele.
Exam: fever; bruises on trunk and blood oozing from IV site and venipuncture
site.
Labs: Fibrinogen 110 mg/dL
A bone marrow is performed and shows immature myeloid cells with azurophilic
needle-shaped cytoplasmic granules.
A t(8;14)
B t(9;22)
C t(14;18)
D t(15;17)
E inv 16
A 43 year old man presents with fatigue, recurrent fever and sore throat. He is
treated with antibiotics without improvement. His wife notes that he has been
bruising easily and has gum bleeding.
Exam: low grade temp; pallor; red throat; bruises on arms and thighs
Blood smear: shown
A t(8;14)
B t(9;22)
C t(11;14)
D t(15;17)
E 13q- (deletion 13 q)
A 32 year old man is seen in his doctor’s office with progressive fatigue, easy
bruising and recurrent episodes of gum bleeding.
These cells contain structures that would stain positive for which of the
following?
A Adenosine deaminase
B Dihydrofolate reductase
C Hypoxanthine-guanine phosphoribosyl transferase
C Monoamine oxidase
D P450 mixed-function oxidase
E Topoisomerase II
F Xanthine oxidase
Purine catabolism (break down of
nucleotides from DNA from nucleus of killed
cells) involves xanthine oxidase, which
converts hypoxanthine to xanthine and
xanthine to uric acid.
This patient most likely has a mutation in which of the following types of proteins?
A Burkitt’s lymphoma
B Chronic myelogenous leukemia
C Follicular lymphoma
D Li-Fraumeni syndrome
E Mantle cell lymphoma
A 66 year old man with hypertension and stage IV chronic kidney disease comes to office for
follow up for worsening fatigue and low energy for the past several months. He has no chest
pain or shortness of breath. He was previously nonadherent with antihypertensive therapy, but
now is taking his medications since renal dysfunction was diagnosed 2 years ago. He is a former
smoker (20 packs/year). He does not drink alcohol or use recreational drugs.
The effects of the hormone prescribed for this patient are most likely mediated by which of the
following pathways?
Exam: Temp 38.8 B/P 110/66 Pulse 110/min; Bronchial breath sounds and crackles
in the right lower lung field
Labs: WBC 54,000/ul
Differential: PMN 68% Bands 10% Myelocytes 3% Metamyelocytes 1%
Lymphs 15%
Hgb 13 g/dL
Platelets 350,000/ul
Leukocyte alkaline phosphatase (LAP) score is elevated
Which is the most likely additional finding to be seen on her blood smear?
Which of the following is the most likely cause of this patient’s increased susceptibility to
infections?
A Aberrant lysosomal transport and fusion in leukocytes
B Decreased production of functional immunoglobulins
C Defective adhesion and transmigration of leukocytes
D Impaired formation of membrane attack complex
E Impaired phagocytic ability to generate superoxide
A 23 year old man presents with a several week history of a rapidly enlarging left jaw
mass. He comes from East Africa. He has no past medical history and takes no
medications.
Exam: Afebrile. Left sided jaw mass with associated bulky cervical adenopathy; the
mass is not red or warm.
Labs HIV negative
Jaw mass biopsy shows numerous mitotic figures and apoptotic bodies.
A bcl2 overexpression
B bcr-abl rearrangement
C c-myc oncogene overexpression
D n-myc oncogene overexpression
E Tyrosine kinase activation
A 42 year old previously healthy woman is seen in the office for fever and sore throat. She denies cough.
Exam: tonsillar exudate and nontender cervical adenopathy measuring 3.5 cm in diameter.
She is treated with oral antibiotics.
At follow up 1 week later her symptoms have resolved. The previously enlarged cervical lymph node has
decreased slightly in size. On several follow up visits over the ensuing year the patient remains
asymptomatic. The size of the cervical lymph node fluctuates, but does not disappear completely.
She is referred to a surgeon and an excisional bx is done.